AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Harte Hanks, Inc.

$4.3 +$1.24 (+40.52%)
NASDAQ · 14 Sep 2026 20:00 UTC
Previous Close
$4.2
Day Range
$4.24$4.38
Year Range
$2$4.5
Market Cap
31.9M
AVG Volume
96.63K
Trailing/Forward PE
-5.62/-
PEG ratio
0.03
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
NASDAQUS
Revenue (USD)
020M40M60M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HHS Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q237.98M
26 Q137.26M
25 Q439.86M
25 Q339.52M
25 Q238.63M
25 Q141.56M
24 Q447.13M
24 Q347.63M
24 Q245.03M
24 Q145.45M
Net Income (USD)
-30M-20M-10M010M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HHS Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q2-5M
26 Q1-628K
25 Q42.2M
25 Q3-2.29M
25 Q2-335K
25 Q1-392K
24 Q4-2.43M
24 Q3142K
24 Q2-27.83M
24 Q1-171K
Operating Income (USD)
-6M-4M-2M02M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HHS Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q2-4.49M
26 Q1-608K
25 Q4140K
25 Q31.05M
25 Q234K
25 Q1-40K
24 Q4-1.55M
24 Q31.9M
24 Q21.37M
24 Q1375K
EBITDA (USD)
-4M-2M02M4M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HHS EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q2-3.67M
26 Q1153K
25 Q4869K
25 Q31.62M
25 Q21.25M
25 Q1509K
24 Q43.18M
24 Q33.77M
24 Q22.82M
24 Q1815K
Cash Flows (USD)
-7.5M-5M-2.5M02.5M5M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HHS Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q2-2.03M
26 Q1-903K
25 Q4-686K
25 Q32.19M
25 Q2-4.87M
25 Q1-923K
24 Q43.42M
24 Q3-4.86M
24 Q21.26M
24 Q1-6.05M
EPS (USD)
-4-20224 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HHS EPS (USD) by quarter
PeriodEPS (USD)
26 Q2-0.67
26 Q1-0.08
25 Q40.3
25 Q3-0.31
25 Q2-0.05
25 Q1-0.05
24 Q4-0.33
24 Q30.02
24 Q2-3.84
24 Q1-0.02
Expenses (USD)
-10M010M20M30MSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HHS Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q28.74M
26 Q15.99M
25 Q428.3M
25 Q36.16M
25 Q225.21M
25 Q125.75M
24 Q429.78M
24 Q37.17M
24 Q229.22M
24 Q129.95M
Cash & Debt (USD)
05M10M15MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HHS Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q25.18M
26 Q14.54M
25 Q45.59M
25 Q36.51M
25 Q24.76M
25 Q18.98M
24 Q49.93M
24 Q35.94M
24 Q210.97M
24 Q111.46M
Debt ratios
-20-1001024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HHS Debt ratios by quarter
PeriodDebt ratios
26 Q2-18.34
26 Q14.49
25 Q43.96
25 Q32.33
25 Q22.06
25 Q11.44
24 Q41.38
24 Q31.26
24 Q21.03
24 Q11.12
Margins
0%20%40%60%80%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HHS Margins by quarter
PeriodMargins
26 Q247.61%
26 Q113.51%
25 Q414.6%
25 Q315.68%
25 Q267.9%
25 Q166.18%
24 Q468.61%
24 Q349.24%
24 Q269.63%
24 Q169.75%
Return on Capital
-150%-100%-50%0%50%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HHS Return on Capital by quarter
PeriodReturn on Capital
26 Q2-32.59%
26 Q1-3.12%
25 Q410.73%
25 Q3-11.5%
25 Q2-1.51%
25 Q1-1.83%
24 Q4-11.22%
24 Q30.67%
24 Q2-135.06%
24 Q1-0.86%
Shares Outstanding
02M4M6M8M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HHS Shares Outstanding by quarter
PeriodShares Outstanding
26 Q27.43M
26 Q17.42M
25 Q47.39M
25 Q37.39M
25 Q27.38M
25 Q17.36M
24 Q47.36M
24 Q37.32M
24 Q27.26M
24 Q17.24M
Dividends (USD)
00.511.52Nov 13Feb 14May 14Aug 14Nov 14Feb 15May 15Aug 15Nov 15Feb 16
HHS Dividends (USD) by quarter
PeriodDividends (USD)
Feb 160.85
Nov 150.85
Aug 150.85
May 150.85
Feb 150.85
Nov 140.85
Aug 140.85
May 140.85
Feb 140.85
Nov 130.85
Employee Count
02K4K6K2016201720182019202020212022202320242025
HHS Employee Count by quarter
PeriodEmployee Count
20251.72K
20241.72K
20231.71K
20221.88K
20211.94K
20201.83K
20191.94K
20182.82K
20175.39K
20165.59K
Book Value Per Share (USD)
0123424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HHS Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q22.07
26 Q12.71
25 Q42.78
25 Q32.69
25 Q23.01
25 Q12.91
24 Q42.95
24 Q32.87
24 Q22.84
24 Q12.76
Total Assets (USD)
050M100M150M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HHS Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q288.06M
26 Q190.41M
25 Q491.83M
25 Q392.71M
25 Q295.02M
25 Q1100.58M
24 Q4101.78M
24 Q3108.13M
24 Q2109.73M
24 Q1113.44M
PE Ratio
0246810med 2.54Jul 22Oct 22Feb 23May 23Sep 23Dec 23Mar 24
HHS PE Ratio by quarter
PeriodPE Ratio
Mar 242.44
Mar 242.46
Mar 242.49
Mar 242.46
Mar 242.52
Feb 242.56
Feb 242.55
Feb 242.56
Feb 242.49
Jan 242.52
Jan 242.49
Jan 242.41
Jan 242.32
Dec 232.21
Dec 232.28
Dec 232.35
Dec 232.29
Dec 232.38
Nov 232.19
Nov 232.3
Nov 231.77
Nov 231.78
Oct 231.57
Oct 231.51
Oct 231.47
Oct 231.66
Sep 231.67
Sep 231.58
Sep 231.59
Sep 231.59
Sep 231.64
Aug 231.65
Aug 231.46
Aug 231.46
Aug 231.33
Jul 231.3
Jul 231.24
Jul 231.18
Jul 231.19
Jun 231.25
Jun 231.26
Jun 231.39
Jun 231.42
Jun 231.36
May 231.35
May 231.2
May 231.31
May 231.2
Apr 231.67
Apr 231.69
Apr 231.72
Apr 231.71
Mar 231.86
Mar 233.78
Mar 234.03
Mar 234.08
Mar 234.64
Feb 234.47
Feb 234.72
Feb 234.61
Feb 234.87
Jan 235.03
Jan 235.69
Jan 235.75
Jan 235.14
Dec 224.96
Dec 224.88
Dec 225.15
Dec 224.78
Dec 224.7
Nov 224.43
Nov 224.38
Nov 225.14
Nov 225.24
Oct 226.01
Oct 225.36
Oct 225.51
Oct 225.42
Sep 225.6
Sep 225.25
Sep 226.11
Sep 227.54
Sep 227.21
Aug 228.09
Aug 228.67
Aug 227.7
Aug 224.13
Jul 224.53
Jul 224.43
Jul 224.23
Jul 224.32
Jul 224.38
Jun 223.67
Jun 223.52
Jun 223.78
Jun 223.29
May 222.99
May 222.92
May 222.92
May 223.72
Free Cash Flow Yield
-40%-30%-20%-10%0%med -17.82%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
HHS Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-4.48%
Sep 26-4.58%
Sep 26-4.51%
Aug 26-4.43%
Aug 26-5.23%
Aug 26-4.48%
Aug 26-25.26%
Jul 26-26.3%
Jul 26-24.1%
Jul 26-23.6%
Jul 26-23.13%
Jul 26-25.6%
Jun 26-27.82%
Jun 26-24%
Jun 26-22.76%
Jun 26-22.67%
May 26-23.04%
May 26-21.98%
May 26-20.57%
May 26-20.58%
May 26-21.18%
Apr 26-21.03%
Apr 26-20.08%
Apr 26-24.59%
Apr 26-23.22%
Mar 26-24.49%
Mar 26-22.5%
Mar 26-0.91%
Mar 26-0.91%
Feb 26-0.92%
Feb 26-0.89%
Feb 26-0.9%
Feb 26-0.86%
Jan 26-0.84%
Jan 26-0.82%
Jan 26-0.82%
Jan 26-0.86%
Jan 26-0.83%
Dec 25-0.76%
Dec 25-0.75%
Dec 25-0.79%
Dec 25-0.79%
Nov 25-0.67%
Nov 25-0.88%
Nov 25-0.85%
Nov 25-35.39%
Oct 25-31.52%
Oct 25-28.33%
Oct 25-28.01%
Oct 25-27%
Oct 25-27%
Sep 25-26.49%
Sep 25-26.42%
Sep 25-25.73%
Sep 25-26.71%
Aug 25-27.23%
Aug 25-26.78%
Aug 25-26.56%
Aug 25-26.64%
Aug 25-4.41%
Jul 25-4.38%
Jul 25-4.48%
Jul 25-3.9%
Jul 25-4.09%
Jun 25-3.8%
Jun 25-3.93%
Jun 25-3.65%
Jun 25-3.46%
May 25-3.31%
May 25-3.17%
May 25-3.33%
May 25-18.75%
May 25-16.95%
Apr 25-18.23%
Apr 25-18.19%
Apr 25-18.43%
Apr 25-17.69%
Mar 25-18.15%
Mar 25-17.73%
Mar 25-19.27%
Mar 25-18.93%
Feb 25-18.78%
Feb 25-19%
Feb 25-18.24%
Feb 25-17.74%
Jan 25-17.8%
Jan 25-18.07%
Jan 25-18.49%
Jan 25-18.45%
Jan 25-17.87%
Dec 24-17.84%
Dec 24-17.74%
Dec 24-16.54%
Dec 24-16.18%
Nov 24-16.43%
Nov 24-16.32%
Nov 24-14.99%
Nov 24-1.72%
Nov 24-1.67%
Oct 24-1.64%
Price to Sales
0.050.10.150.20.250.3med 0.15Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
HHS Price to Sales by quarter
PeriodPrice to Sales
Sep 260.21
Sep 260.2
Sep 260.21
Aug 260.21
Aug 260.18
Aug 260.21
Aug 260.11
Jul 260.1
Jul 260.11
Jul 260.12
Jul 260.12
Jul 260.11
Jun 260.1
Jun 260.11
Jun 260.12
Jun 260.12
May 260.12
May 260.13
May 260.13
May 260.13
May 260.13
Apr 260.13
Apr 260.13
Apr 260.11
Apr 260.12
Mar 260.11
Mar 260.12
Mar 260.12
Mar 260.12
Feb 260.12
Feb 260.13
Feb 260.12
Feb 260.13
Jan 260.13
Jan 260.14
Jan 260.14
Jan 260.13
Jan 260.14
Dec 250.15
Dec 250.15
Dec 250.14
Dec 250.14
Nov 250.17
Nov 250.13
Nov 250.13
Nov 250.12
Oct 250.13
Oct 250.15
Oct 250.15
Oct 250.15
Oct 250.15
Sep 250.16
Sep 250.16
Sep 250.16
Sep 250.15
Aug 250.15
Aug 250.15
Aug 250.16
Aug 250.16
Aug 250.14
Jul 250.14
Jul 250.14
Jul 250.16
Jul 250.15
Jun 250.16
Jun 250.16
Jun 250.17
Jun 250.18
May 250.18
May 250.19
May 250.18
May 250.18
May 250.2
Apr 250.18
Apr 250.19
Apr 250.18
Apr 250.19
Mar 250.19
Mar 250.19
Mar 250.19
Mar 250.2
Feb 250.2
Feb 250.2
Feb 250.21
Feb 250.21
Jan 250.21
Jan 250.21
Jan 250.2
Jan 250.2
Jan 250.21
Dec 240.21
Dec 240.21
Dec 240.23
Dec 240.23
Nov 240.23
Nov 240.23
Nov 240.25
Nov 240.27
Nov 240.28
Oct 240.28
EV/EBITDA
246810med 5.01Nov 24Feb 25Jun 25Sep 25Jan 26Apr 26Aug 26
HHS EV/EBITDA by quarter
PeriodEV/EBITDA
Aug 268.84
Jul 268.67
Jul 269.05
Jul 269.14
Jul 269.24
Jul 268.78
Jun 268.44
Jun 269.07
Jun 269.31
Jun 269.33
May 269.26
May 269.49
May 269.83
May 268.87
May 268.73
Apr 268.76
Apr 268.99
Apr 268.07
Apr 268.31
Mar 268.09
Mar 268.45
Mar 265.46
Mar 265.46
Feb 265.42
Feb 265.52
Feb 265.49
Feb 265.63
Jan 265.74
Jan 265.82
Jan 265.82
Jan 265.64
Jan 265.77
Dec 256.07
Dec 256.11
Dec 255.92
Dec 255.94
Nov 256.57
Nov 255.57
Nov 255.68
Nov 254.41
Oct 254.7
Oct 255
Oct 255.03
Oct 255.14
Oct 255.14
Sep 255.2
Sep 255.21
Sep 255.29
Sep 255.17
Aug 255.11
Aug 255.17
Aug 255.19
Aug 255.18
Aug 253.88
Jul 253.9
Jul 253.84
Jul 254.2
Jul 254.07
Jun 254.27
Jun 254.18
Jun 254.39
Jun 254.55
May 254.7
May 254.84
May 254.67
May 254.53
May 254.86
Apr 254.62
Apr 254.62
Apr 254.58
Apr 254.71
Mar 254.63
Mar 254.71
Mar 253.63
Mar 253.68
Feb 253.7
Feb 253.67
Feb 253.77
Feb 253.84
Jan 253.83
Jan 253.79
Jan 253.73
Jan 253.74
Jan 253.82
Dec 243.82
Dec 243.84
Dec 244.02
Dec 244.09
Nov 244.04
Nov 244.06
Nov 244.31
Nov 244.39
Nov 244.49
Oct 244.54
Oct 244.53
Oct 244.62
Oct 244.35
Sep 244.55
Sep 244.63
Sep 244.68
Price/Operating Cashflow
0102030med 12.51Oct 23Feb 24May 24Sep 24Jun 25Jan 26Sep 26
HHS Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2624.49
Sep 2623.92
Sep 2624.31
Aug 2624.71
Aug 2620.95
Aug 2624.49
Mar 2611.57
Mar 2611.57
Feb 2611.45
Feb 2611.82
Feb 2611.7
Feb 2612.2
Jan 2612.62
Jan 2612.91
Jan 2612.91
Jan 2612.24
Jan 2612.74
Dec 2513.82
Dec 2513.99
Dec 2513.28
Dec 2513.36
Nov 2515.7
Nov 2511.99
Nov 2512.41
Aug 2511.32
Jul 2511.42
Jul 2511.15
Jul 2512.81
Jul 2512.22
Jun 2513.15
Jun 2512.71
Jun 2513.68
Jun 2514.44
May 2515.11
May 2515.77
May 2515.01
Nov 2426.74
Nov 2427.51
Oct 2427.93
Oct 2427.89
Oct 2428.55
Oct 2426.44
Sep 2428.05
Sep 2428.62
Sep 2429.08
Sep 2428.09
Aug 2428.85
Aug 2428.89
Aug 2428.2
Aug 2427.47
Aug 2421.36
Jul 2421.61
Jul 2421.26
Jul 2421.44
Jul 2422.23
Jun 2420.7
Jun 2419.68
Jun 2419.8
Jun 2418.68
May 2418.68
May 2418.84
May 2419.32
May 2417.82
May 245.1
Apr 245.13
Apr 245.01
Apr 245.01
Apr 245.01
Mar 243.36
Mar 243.38
Mar 243.43
Mar 243.39
Mar 243.47
Feb 243.52
Feb 243.51
Feb 243.52
Feb 243.43
Jan 243.46
Jan 243.43
Jan 243.31
Jan 243.19
Dec 233.05
Dec 233.15
Dec 233.23
Dec 233.15
Dec 233.28
Nov 233.02
Nov 233.17
Nov 231.88
Nov 231.89
Oct 231.67
Oct 231.61
Oct 231.56
Oct 231.77
Sep 231.77
Sep 231.68
Sep 231.7
Sep 231.69
Sep 231.75
Aug 231.76
Price to Book
0.511.522.53med 1.23Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
HHS Price to Book by quarter
PeriodPrice to Book
Sep 262.08
Sep 262.03
Sep 262.07
Aug 262.1
Aug 261.78
Aug 262.08
Aug 260.84
Jul 260.81
Jul 260.88
Jul 260.9
Jul 260.92
Jul 260.83
Jun 260.76
Jun 260.89
Jun 260.93
Jun 260.94
May 260.92
May 260.97
May 261.03
May 261.02
May 260.99
Apr 260.99
Apr 261.04
Apr 260.85
Apr 260.9
Mar 260.85
Mar 260.93
Mar 261.03
Mar 261.03
Feb 261.02
Feb 261.06
Feb 261.04
Feb 261.09
Jan 261.13
Jan 261.15
Jan 261.15
Jan 261.09
Jan 261.14
Dec 251.23
Dec 251.25
Dec 251.19
Dec 251.19
Nov 251.4
Nov 251.07
Nov 251.11
Nov 250.92
Oct 251.03
Oct 251.15
Oct 251.16
Oct 251.2
Oct 251.2
Sep 251.23
Sep 251.23
Sep 251.26
Sep 251.22
Aug 251.19
Aug 251.21
Aug 251.22
Aug 251.22
Aug 251.17
Jul 251.18
Jul 251.15
Jul 251.33
Jul 251.26
Jun 251.36
Jun 251.32
Jun 251.42
Jun 251.49
May 251.56
May 251.63
May 251.55
May 251.53
May 251.7
Apr 251.58
Apr 251.58
Apr 251.56
Apr 251.62
Mar 251.58
Mar 251.62
Mar 251.73
Mar 251.76
Feb 251.78
Feb 251.76
Feb 251.83
Feb 251.88
Jan 251.88
Jan 251.85
Jan 251.81
Jan 251.81
Jan 251.87
Dec 241.87
Dec 241.88
Dec 242.02
Dec 242.06
Nov 242.03
Nov 242.05
Nov 242.23
Nov 242.46
Nov 242.53
Oct 242.57
Harte Hanks, Inc.
HHS
Stockpicker

Video analysis: HHS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: HHS

HHS plans new FDA deputy commissioner roles for technology and drugs, sources say

cnbc.com · 25 Aug 2026

HHS plans new FDA deputy commissioner roles for technology and drugs, sources say

The Department of Health and Human Services is planning to appoint deputy commissioners for technology and drugs at the FDA, creating new roles at the agency, CNBC has learned. Like existing deputy commissioner roles, the two new positions would report into Trump's pick for FDA commissioner, Heidi Overton, who still needs to be confirmed by the Senate.

$HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the Merger - CHMI, VREX, HHS and ARX

gurufocus.com · 23 Aug 2026

$HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the Merger - CHMI, VREX, HHS and ARX

$HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the Merger - CHMI, VREX, HHS and ARX PR Newswire

Are MITT, ARX, HHS, FULC Obtaining Fair Deals for their Shareholders?

gurufocus.com · 17 Aug 2026

Are MITT, ARX, HHS, FULC Obtaining Fair Deals for their Shareholders?

Are MITT, ARX, HHS, FULC Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Aug. 17, 2026

Are MITT, ARX, HHS, FULC Obtaining Fair Deals for their Shareholders?

prnewswire.com · 17 Aug 2026

Are MITT, ARX, HHS, FULC Obtaining Fair Deals for their Shareholders?

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws

Shareholder Alert: Ademi LLP investigates whether Harte Hanks, Inc. is obtaining a Fair Price for Public Shareholders

prnewswire.com · 14 Aug 2026

Shareholder Alert: Ademi LLP investigates whether Harte Hanks, Inc. is obtaining a Fair Price for Public Shareholders

MILWAUKEE, Aug. 14, 2026 /PRNewswire/ -- Ademi LLP is investigating Harte Hanks (NASDAQ: HHS) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Star Equity. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995.

HHS Stock Alert: Halper Sadeh LLC is Investigating Whether Harte Hanks, Inc. is Obtaining a Fair Price for its Shareholders

businesswire.com · 14 Aug 2026

HHS Stock Alert: Halper Sadeh LLC is Investigating Whether Harte Hanks, Inc. is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Harte Hanks, Inc. (NASDAQ: HHS) to Star Equity Holdings, Inc. Under the terms of the proposed transaction, Harte Hanks shareholders may elect to receive either (1) $5.00 in cash for each Harte Hanks share, or (2) 0.50 shares of Star Equity's publicly traded 10% Series A Cumulative Perpetual Preferred Stock for each Harte Hanks share. Halper Sadeh encourages Harte Hanks shareholders to click he.

Star Equity Holdings Enters Into Merger Agreement to Acquire Harte Hanks

globenewswire.com · 14 Aug 2026

Star Equity Holdings Enters Into Merger Agreement to Acquire Harte Hanks

Transaction Expands Star's Business Services Platform, Enhances Revenue Diversity, and is Expected to Drive Significant Cost Synergies and Earnings Accretion  Harte Hanks Stockholders to Receive $5.00 per Share, Consisting of Cash and Star Preferred Stock OLD GREENWICH, Conn., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (“Star”) (Nasdaq: STRR; STRRP), a diversified holding company, announced today that it has entered into a merger agreement (the “Merger Agreement”) to acquire Harte Hanks, Inc. (the “Merger”) (“Harte Hanks”) (Nasdaq: HHS), a global customer experience and business process outsourcing company (together with Star, the “Companies”).

Harte Hanks Enters Definitive Agreement to Be Acquired by Star Equity Holdings for $5.00 Per Share

accessnewswire.com · 14 Aug 2026

Harte Hanks Enters Definitive Agreement to Be Acquired by Star Equity Holdings for $5.00 Per Share

Transaction Represents an Approximately 100% Premium to Harte Hanks' Unaffected Share Price Harte Hanks Shareholders to Receive 50% Cash and 50% in Star Equity 10% Preferred Stock CHELMSFORD, MA / ACCESS Newswire / August 14, 2026 / Harte Hanks, Inc. (NASDAQ:HHS) ("Harte Hanks" or the "Company") and Star Equity Holdings, Inc. (NASDAQ:STRR)(NASDAQ:STRRP) ("Star Equity") today announced they have entered into a definitive merger agreement under which Star Equity will acquire all outstanding shares of Harte Hanks common stock for $5.00 per share, or $38.4 million in aggregate equity value. The Harte Hanks Board of Directors unanimously approved the transaction and recommends Harte Hanks shareholders vote in favor of the transaction.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.